Tonix Pharmaceuticals Holding (TNXP) EBT Margin (2023 - 2025)
Historic EBT Margin for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to 967.66%.
- Tonix Pharmaceuticals Holding's EBT Margin fell 4064600.0% to 967.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 948.86%, marking a year-over-year increase of 3072300.0%. This contributed to the annual value of 1354.28% for FY2024, which is 900700.0% down from last year.
- Per Tonix Pharmaceuticals Holding's latest filing, its EBT Margin stood at 967.66% for Q3 2025, which was down 4064600.0% from 1369.02% recorded in Q2 2025.
- Tonix Pharmaceuticals Holding's EBT Margin's 5-year high stood at 561.2% during Q3 2024, with a 5-year trough of 3501.59% in Q2 2024.
- Over the past 3 years, Tonix Pharmaceuticals Holding's median EBT Margin value was 860.23% (recorded in 2024), while the average stood at 1135.06%.
- Over the last 5 years, Tonix Pharmaceuticals Holding's EBT Margin had its largest YoY gain of 21325700bps in 2025, and its largest YoY loss of -4064600bps in 2025.
- Tonix Pharmaceuticals Holding's EBT Margin (Quarter) stood at 723.0% in 2023, then decreased by -20bps to 870.64% in 2024, then decreased by -11bps to 967.66% in 2025.
- Its last three reported values are 967.66% in Q3 2025, 1369.02% for Q2 2025, and 660.93% during Q1 2025.